References
Chirinos JA, Segers P, Gillebert TC, Gupta AK, De Buyzere ML, De Bacquer D, St John-Sutton M, Rietzschel ER, on behalf of the Asklepios Investigators. Arterial properties as determinants of time-varying myocardial stress in humans. Hypertension. 2012;60:64–70.
Chirinos JA, Segers P, Rietzschel ER, De Buyzere ML, Raja MW, Claessens T, De Bacquer D, St John-Sutton M, Gillebert TC, Asklepios Investigators. Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-aged adults: the Asklepios study. Hypertension. 2013;61:296–303.
Perticone F, Maio R, Cosco C, Ceravolo R, Iacopino S, Chello M, Mastroroberto P, Tramontano D, Mattioli PL. Hypertensive left ventricular remodeling and ACE-gene polymorphism. Cardiovasc Res. 1999;43:192–9.
Schunkert H, Hense HW, Homer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634–8.
Milano CA, Dolber PC, Rockman HA, Bond RA, Venable WE, Allen LF, Lefkowits RJ. Myocardial expresión of a constitutively active alpha 1B—adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 1994;91:10109–13.
Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptative physiologic response. FASEB J. 1991;5:3037–46.
Cuspidi C, Facchetti R, Sala C, Bombelli M, Negri F, Carugo S, Sega R, Grassi G, Mancia G. Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study. J Hypertens. 2012;30:997–1003.
Devereux RB, Pini R, Aurigemma GP, Roman MJ. Measurement of left ventricular mass: methodology and expertise. J Hypertens. 1997;15:801–9.
Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlôf B, Aalto T, Toman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. Hypertension. 2000;35:6–12.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–8.
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.
Piskorz D, Bongarzoni L, Citta L, Citta N, Citta P, Keller L, Tommasi A, Piskorz G. ESH/ESC 2007 vs 2013 guidelines are the left ventricular hypertrophy diagnostic tools changing? Hipertens Riesgo Vasc. 2014;31:119–24.
Sahn DJ, De Maria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–83.
Ilercil A, O’Grady MJ, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Howard BV, Devereux RB. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. J Am Soc Echocardiogr. 2001;14:601–11.
Baldo MP, Gonçalves MA, Ca**ana DP, et al. Prevalence and clinical correlates of left ventricular hypertrophy in black Africans. High Blood Press Cardiovasc Prev. 2018. https://doi.org/10.1007/s40292-018-0267-y.
de la Sierra A, Banegas JR, Vinyoles E, Segura J, Gorostidi M, de la Cruz JJ, Ruilope LM. Prevalence of masked hypertension in untreated and treated patients with office blood pressure below 130/80 mmHg. Circulation. 2018;137:2651–3.
Bromfield SG, Shimbo D, Bertoni AG, Sims M, Carson AP, Muntner P. Ambulatory blood pressure monitoring phenotypes among individuals with and without diabetes taking antihypertensive medication: the Jackson Heart Study. J Human Hypertens. 2016;30:731–6.
Malmqvist K, Ohman KP, Lind L, Nystrom F, Kahan T. Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin. J Intern Med. 2002;252:430–9.
Hong SJ, Park CG, Seo HS, Oh DJ, Ro YM. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press. 2004;13:236–42.
Wong CY, Wong CY, O’Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation. 2004;110:3081–7.
Chirinos JA, Segers P, De Buyzere ML, Kronmal RA, Raja MR, De Bacquer D, Claessens T, Gillebert TC, St. John-Sutton M, Rietzschel ER. Left ventricular mass. Allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010;56:91–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Piskorz, D. Ethnicity and Left Ventricular Hypertrophy: Tools and Uncertainties. High Blood Press Cardiovasc Prev 25, 291–294 (2018). https://doi.org/10.1007/s40292-018-0271-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-018-0271-2